Evidence for antigen presentation to sensitized T cells by thyroid peroxidase (TPO)-specific B cells in mice injected with fibroblasts co- expressing TPO and MHC class II

Clinical and Experimental Immunology

Volumn 119, Issue 1, 2000, Pages 38-46

  Guo, J ^a   Wang, Y ^a   Rapoport, B ^a   McLachlan, S M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Antigen presentation; Iodide; T cell proliferation; Thyroid peroxidase; Thyroid peroxidase specific B cells

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; THYROID HORMONE; THYROID PEROXIDASE; THYROXINE;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; ENZYME SPECIFICITY; FEMALE; FIBROBLAST; HASHIMOTO DISEASE; LYMPHOCYTIC INFILTRATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGEN PRESENTATION; AUTOANTIBODIES; AUTOIMMUNITY; B-LYMPHOCYTES; FEMALE; FIBROBLASTS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IODIDE PEROXIDASE; IODINE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED AKR; SPLEEN; T-LYMPHOCYTES; THYROID GLAND; TRANSPLANTATION, AUTOLOGOUS;

EID: 0033980502     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01087.x     Document Type: Article

References (47)

1. 1 McLachlan SM, Rapoport B. The molecular biology of thyroid peroxidase: cloning, expression and role as autoantigen in autoimmune thyroid disease. Endocr Rev 1992; 13:192-206.
2. 2 Bigazzi PE, Rose NR. Spontaneous autoimmune thyroiditis in animals as a model of human disease. Prog Allergy 1975; 19:245-74.
3. 3 Wick G, Most J, Schauenstein K et al. Spontaneous autoimmune thyroiditis - a bird's eye view. Immunol Today 1985; 6:359-65.
4. 4 Rasooly L, Burek CL, Rose NR. Iodine-induced autoimmune thyroidis tis in NOD-H2h4 mice. Clin Immunol Immunopathol 1996; 81:287-92.
5. 5 Kotani T, Umeki K, Hirai K, Ohtaki S. Experimental murine thyroiditis induced by porcine thyroid peroxidase and its transfer by the antigen-specific T cell line. Clin Exp Immunol 1990; 80:11-8.
6. 6 McLachlan SM, Atherton MC, Nakajima Y et al. Thyroid peroxidase and the induction of autoimmune thyroid disease. Clin Exp Immunol 1990; 79:182-8.
7. 7 Nye L, Pontes de Carvalho LC, Roitt IM. Restrictions in the response to autologous thyroglobulin in the human. Clin Exp Immunol 1980; 41:252-63.
8. 8 Ruf J, Toubert M, Czarnocka B, Durand-Gorde J, Ferrand M, Carayon P. Relationship between immunological structure and bios chemical properties of human thyroid peroxidase. Endocrinol 1989; 125:1211-8.
9. 9 McLachlan SM, Rapoport B. Genetic and epitopic analysis of thyroid peroxidase (TPO) autoantibodies: markers of the human thyroid autoimmune response. Clin Exp Immunol 1995; 101:200-6.
10. 10 Heidenreich F, Vincent A, Roberts A, Newsom-Davis J. Epitopes on human acetylcholine receptor defined by monoclonal antibodies and myasthenia gravis sera. Autoimmunity 1988; 1:285-97.
11. 11 Jaume JC, Guo J, Wang Y, Rapoport B, McLachlan SM. Cellular thyroid peroxidase (TPO), unlike purified TPO and adjuvant, induces antibodies in mice that resemble autoantibodies in human autoimmune thyroid disease. J Clin Endocrinol Metab 1999; 84:1651-7.
12. 12 Rapoport B, Chazenbalk GD, Jaume JC, McLachlan SM. The thyrotropin receptor: interaction with thyrotropin and autoantibodies. Endocr Rev 1998; 19:673-716.
13. 13 Shimojo N, Kohno Y, Yamaguchi K-I et al. Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule. Proc Natl Acad Sci USA 1996; 93:11074-9.
14. 14 Kita M, Ahmad L, Marians RC et al. Regulation and transfer of a murine model of thyrotropin receptor antibody mediated Graves' disease. Endocrinol 1999; 140:1392-8.
15. 15 Jaume JC, Rapoport B, McLachlan SM. Lack of female bias in a mouse model of autoimmune hyperthyroidism (Graves' disease). Autoimmunity 1999; 29:269-72.
16. 16 Weetman AP, McGregor AM. Autoimmune thyroid disease: further developments in our understanding. Endocr Rev 1994; 15:788-830.
17. 2-terminal domain of the class II major histocompatibility polypeptide Aβ. Proc Natl Acad Sci USA 1985; 82:2940-4.
18. 18 Magnusson RP, Chazenbalk GD, Gestautas J et al. Molecular cloning of the complementary deoxyribonucleic acid for human thyroid peroxidase. Mol Endocrinol 1987; 1:856-61.
19. 19 Mahmoud I, Colin I, Many M-C, Denef J-F. Direct toxic effect of iodide in excess on iodine-deficient thyroid glands: epithelial necrosis and inflammation associated with lipofuscin accumulation. Exp Mol Pathol 1986; 44:259-71.
20. 20 Guo J, McLachlan SM, Hutchison JS, Rapoport B. The greater glycan content of recombinant human thyroid peroxidase of mammalian than of insect cell origin facilitates purification to homogeneity of enzymatically active protein remaining soluble at high concentration. Endocrinol 1998; 139:999-1005.
21. 21 Harlow E, Lane D. Antibodies. A laboratory manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1988.
22. 22 Chazenbalk GD, Costante G, Portolano S, McLachlan SM, Rapoport B. The immunodominant region on human thyroid peroxidase recognized by autoantibodies does not contain the monoclonal antibody 47/c21 linear epitope. J Clin Endocrinol Metab 1993; 77:1715-8.
23. 23 McLachlan SM, McGregor A, Rees Smith B, Hall R. Thyroid-auto-antibody synthesis by Hashimoto thyroid lymphocytes. Lancet 1979; i: 162-3.
24. 24 Ingbar SH. Autoregulation of the thyroid. Response to iodide excess and depletion. Mayo Clin Proc 1972; 47:814-23.
25. 25 Bagchi N, Brown TR, Urdanivia E, Sundick RS. Induction of autoimmune thyroiditis in chickens by dietary iodine. Science 1985; 230:325-7.
26. 26 Allen EM, Appel MC, Braverman LE. The effect of iodide ingestion on the development of spontaneous lymphocytic thyroiditis in the diabetes-prone BB/W rat. Endocrinol 1986; 118:1977-81.
27. 27 Mooij P, De Wit HJ, Drexhage HA. An excess of dietary iodine accelerates the development of a thyroid-associated lymphoid tissue in autoimmune prone BB rats. Clin Immunol Immunopathol 1993; 69:189-98.
28. 28 Cohen SB, Weetman AP. The effect of iodide depletion and supplementation in the Buffalo strain rat. J Endocrinol Invest 1988; 11:625-7.
29. 29 Weetman AP, McGregor AM, Campbell H, Lazarus JH, Ibbertson HK, Hall R. Iodide enhances IgG synthesis by human peripheral blood lymphocytes in vitro. Acta Endocrinol (Copenh) 1983; 103:210-5.
30. 30 Yamaguchi K-I, Shimojo N, Kikuoka S et al. Genetic control of anti-thyrotropin receptor antibody generation in H-2k mice immunized with thyrotropin receptor-transfected fibroblasts. J Clin Endocrinol Metab 1997; 82:4266-9.
31. 31 Scopsi L, Collini P, Sampietro G, Boracchi P, Pilotti S. Prognostic impact of thyroid lymphocytic infiltration in patients with medullary thyroid carcinoma. Thyroid 1996; 6:613-7.
32. 32 Kong YM, Simon LL, Creemers P, Rose N. In vitro T cell proliferation and cytotoxicity in murine autoimmune thyroiditis. Mount Sinai J Med 1986; 53:46-52.
33. 33 Janeway CA Jr. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harbor Quant Biol 1989; 54:1-13.
34. 34 Medzhitov R, Janeway CA Jr. Innate immune recognition and control of adaptive immune responses. Semin Immunol 1998; 10:351-3.
35. 35 Rasooly L, Rose NR, Saboori AM, Ladenson PW, Burek CL. Iodine is essential for human T cell recognition of human thyroglobulin. Autos immunity 1998; 27:213-9.
36. 36 Dayan CM, Londei M, Corcoran AE et al. Autoantigen recognition by thyroid-infiltrating T cells in Graves disease. Proc Natl Acad Sci USA 1991; 88:7415-9.
37. 37 Mullins RJ, Chernajovsky Y, Dayan C, Londei M, Feldmann M. Transfection of thyroid autoantigens into EBV-transformed B cell lines. J Immunol 1994; 152:5572-80.
38. 38 Martin A, Magnusson RP, Kendler DL, Concepcion E, Ben-Nun A, Davies TF. Endogenous antigen presentation by autoantigen-transfected Epstein-Barr virus-lymphoblastoid cells. J Clin Invest 1993; 91:1567-74.
39. 39 Matsuo H, Batocchi A-P, Hawke S et al. Peptide-selccted T cell lines from myasthenia gravis patients and controls recognize epitopes that are not processed from whole acetylcholine receptor. J Immunol 1995; 155:3683-92.
40. 40 Weetman AP, McGregor AM, Rennie DP, Hall R. Sites of auto-antibody production in rats with thyroiditis. Immunol 1982; 46:465-72.
41. 41 Hutchings P, Rayner DC, Champion BR et al. High efficiency antigen presentation by thyroglobulin-primed murine splenic B cells. Eur J Immunol 1987; 17:393-8.
42. 42 Bottazzo GF, Pujol-Borrell R, Hanafusa T, Feldmann M. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 1983; ii:1115-8.
43. null mice. J Exp Med 1996; 184:2049-53.
44. 44 Falcone M, Lee J, Patstone G, Yeung B, Sarvetnick N. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice. J Immunol 1998; 161:1163-8.
45. 45 Simitsek PD, Campbell DG, Lanzavecchia A, Fairweather N, Watts C. Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants. J Exp Med 1995; 181:1957-63.
46. 46 Dai Y, Carayanniotis KA, Eliades P et al. Enhancing or suppressive effects of antibodies on processing of a pathogenic T cell epitope in thyroglobulin. J Immunol 1999; 162:6987-92.
47. 47 Lanzavecchia A. How can cryptic epitopes trigger autoimmunity? J Exp Med 1995; 181:1945-8.